SEC Comment Letter for Inventiva S.A. (IVA, IVEVF) (CIK 0001756594) (IVA) — Aug 4, 2021
Inventiva S.A. (IVA, IVEVF) (CIK 0001756594)
Date: Aug. 4, 2021 · CIK: 0001756594 · Accession: 0000000000-21-009556
AI Filing Summary & Sentiment
File numbers found in text: 333-258369
Letter
United States securities and exchange commission logo August 4, 2021 Frédéric Cren Chief Executive Officer Inventiva S.A. 50 rue de Dijon 21121 Daix France Re:Inventiva S.A. Registration Statement on Form F-3 Filed August 2, 2021 File No. 333-258369 Dear Mr. Cren: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dillon Hagius at 202-551-7967 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jean Volatier
Show Raw Text
United States securities and exchange commission logo
August 4, 2021
Frédéric Cren
Chief Executive Officer
Inventiva S.A.
50 rue de Dijon
21121 Daix France
Re:Inventiva S.A.
Registration Statement on Form F-3
Filed August 2, 2021
File No. 333-258369
Dear Mr. Cren:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dillon Hagius at 202-551-7967 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jean Volatier